Racial disparities in laryngeal cancer treatment and outcome: A population-based analysis of 24,069 patients

Laryngoscope

Volumn 125, Issue 7, 2015, Pages 1667-1674

  Shin, Jacob Y ^a   Truong, Minh T ^a,b  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

disparities; Laryngeal cancer; outcomes; race; treatment

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN; CANCER GRADING; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHI SQUARE TEST; EUROPEAN AMERICAN; FEMALE; HISPANIC; HUMAN; KAPLAN MEIER METHOD; LARYNGECTOMY; LARYNX SQUAMOUS CELL CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRESERVATION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE; RETROSPECTIVE STUDY; ADOLESCENT; AGED; ANCESTRY GROUP; CANCER REGISTRY; EPIDEMIOLOGY; ETHNOLOGY; HEALTH SURVEY; LARYNGEAL NEOPLASMS; MIDDLE AGED; MORBIDITY; MULTIMODALITY CANCER THERAPY; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TREATMENT OUTCOME; TRENDS; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MORBIDITY; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84932194232     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.25212     Document Type: Article

References (22)

1. Siegel R, Ma J, Zou Z, et al., Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29.
2. Gourin CG, Conger BT, Sheils WC, et al., The effect of treatment on survival in patients with advanced laryngeal carcinoma. Laryngoscope 2009; 119: 1312-1317.
3. Gourin CG, Podolsky RH,. Racial disparities in patients with head and neck squamous cell carcinoma. Laryngoscope 2006; 116: 1093-1106.
4. Hashibe M, Brennan P, Benhamou S, et al., Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 2007; 99: 777-789.
5. Goodwin WJ, Thomas GR, Parker DF, et al., Unequal burden of head and neck cancer in the United States. Head Neck 2008; 30: 358-371.
6. DeSantis C, Naishadham D, Jemal A,. Cancer statistics for African Americans, 2013. CA Cancer J Clin 2013; 63: 151-166.
7. Ragin CC, Langevin SM, Marzouk M, et al., Determinants of head and neck cancer survival by race. Head Neck 2011; 33: 1092-1098.
8. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991; 324: 1685-1690.
9. Hoffman HT, Porter K, Karnell LH, et al., Laryngeal cancer in the United States: Changes in demographics, patterns of care, and survival. Laryngoscope 2006; 116: 1-13.
10. Surveillance, Epidemiology, and End Results (SEER) Program. National Cancer Institute. Available at: http://www.seer.cancer.gov. Last accessed November 1, 2014.
11. Roach M III, Alexander M, Coleman JL,. The prognostic significance of race and survival from laryngeal carcinoma. J Natl Med Assoc 1992; 84: 668-674.
12. Hou WH, Daly ME, Lee NY, et al., Racial disparities in the use of voice preservation therapy for locally advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 2012; 138: 644-649.
13. Chen AY, Fedewa S, Zhu J,. Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States, 1985-2007. Arch Otolaryngol Head Neck Surg 2011; 137: 1017-1024.
14. Terrell JE, Fisher SG, Wolf GT,. Long-term quality of life after treatment of laryngeal cancer. The Veterans Affairs Laryngeal Cancer Study Group. Arch Otolaryngol Head Neck Surg 1998; 124: 964-971.
15. Ackerstaff AH, Fuller D, Irvin M, et al., Multicenter study assessing effects of heat and moisture exchanger use on respiratory symptoms and voice quality in laryngectomized individuals. Otolaryngol Head Neck Surg 2003; 129: 705-712.
16. NCCN Guidelines. National Comprehensive Cancer Network. Available at: http://www.nccn.org/professionals/physician-gls/f-guidelines.asp#site. Last accessed November 1, 2014.
17. Dey P, Arnold D, Wight R, et al., Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer. Cochrane Database Syst Rev 2002: CD002027.
18. Forastiere AA, Zhang Q, Weber RS, et al., Long-term results of RTOG 91-11: A comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 2013; 31: 845-852.
19. Pointreau Y, Garaud P, Chapet S, et al., Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 2009; 101: 498-506.
20. Hitt R, Grau JJ, Lopez-Pousa A, et al., A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer. Ann Oncol 2014; 25: 216-225.
21. Haddad R, O'Neill A, Rabinowits G, et al., Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): A randomised phase 3 trial. Lancet Oncol 2013; 14: 257-264.
22. Sandulache VC, Kubik MW, Skinner HD, et al., Impact of race/ethnicity on laryngeal cancer in patients treated at a Veterans Affairs Medical Center. Laryngoscope 2013; 123: 2170-2175.